CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 310 enrolled
Drug / intervention
Natriuresisother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04606927
NCT04606927N/ACompleted

Pragmatic Urinary Sodium-based Treatment algoritHm in Acute Heart Failure

University Medical Center Groningen·interventional·Posted Oct 28, 2020·Updated Apr 22, 2024

In Brief

A clinical study evaluating Natriuresis for Heart Failure Acute. Completed, enrolled 310 participants across 1 site.

Detailed Summary

Administration of loop diuretics to achieve decongestion is the current cornerstone of therapy for acute heart failure. Unfortunately, there is a lack of evidence of how to guide diuretic treatment. Recently, urinary sodium, as a response measure of diuretic response, has been proposed as a target for therapy. The hypothesis of this study is that natriuresis guided therapy in patients with acute heart failure will improve diuretic response, decongestion, and reduce length of hospital stay, as well as heart failure rehospitalisations.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesNetherlands
Collaborators--

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedOct 28, 2020
Enrollment StartFeb 1, 2021
Primary CompletionMay 9, 2023
Study CompletionJun 1, 2023
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 5.7 years ago

Interventions

Natriuresisother

Patients with insufficient decongestive response based on natriuresis (in the active arm) will be eligible for treatment adjustments according to the natriuresis guided treatment algorithm.